These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1282572)

  • 21. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
    Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest.
    Haas R; Hohaus S; Egerer G; Ehrhardt R; Witt B; Hunstein W
    Bone Marrow Transplant; 1992 Jun; 9(6):459-65. PubMed ID: 1352717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New therapy of patients with malignant lymphoma using G-CSF].
    Asano S
    Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):924-7. PubMed ID: 7525813
    [No Abstract]   [Full Text] [Related]  

  • 25. Mobilization of peripheral blood progenitor cells following CHOP treatment combined with delayed granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma.
    Takano H; Sawada K; Sato N; Natoya A; Tarumi T; Hirayama S; Koizumi K; Takahashi TA; Sekiguchi S; Koike T
    Leuk Lymphoma; 1996 May; 21(5-6):473-8. PubMed ID: 9172813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A clinical study of recombinant human G-CSF in gynecological tumor patients with neutropenia due to chemotherapy (rG.CSF Clinical Study Group)].
    Terashima Y; Ochiai K; Hashimoto M; Nishiya I; Takamizawa H; Hasumi K; Takada M; Akiya K; Negishi Y; Takeda Y
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1461-71. PubMed ID: 1698901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of rhG-CSF on infection complications and impaired function of neutrophils secondary to chemotherapy for non-Hodgkin's lymphoma. Hokkaido Study Group of Malignant Lymphoma, and rhG-CSF, Japan.
    Kuni-Eda Y; Okabe M; Kurosawa M; Maekawa I; Higuchi M; Kawamura M; Morioka M; Suzuki S; Ohmura T; Fujimoto N
    Leuk Lymphoma; 1995 Feb; 16(5-6):471-6. PubMed ID: 7540462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of rhG-CSF increases complete remission rates after CHOP and ProMACE/CytaBOM for non-Hodgkin's lymphoma: a pilot study. Hokkaido Study Group of Malignant Lymphoma and rhG-CSF.
    Okabe M; Maekawa I; Suzuki S; Higuchi M; Morioka M; Nishi K; Itaya T; Ohmura T; Kawamura M; Fuzimoto N
    Leuk Lymphoma; 1995 Nov; 19(5-6):485-91. PubMed ID: 8590851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of recombinant human granulocyte colony-stimulating factor on superoxide production by neutrophil in cancer patients receiving chemotherapy].
    Yoshida M; Oshi M; Aso Y; Yanagisawa R; Kishi H; Ishida Y
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1262-8. PubMed ID: 7689123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of continuous subcutaneous administration of a small dose of granulocyte colony stimulating factor (G-CSF) by the use of a portable infusion pump in patients with non-Hodgkin's lymphoma receiving chemotherapy.
    Furuya H; Wakayama T; Ohguni S; Yamauchi K; Tanaka J; Hatazoe T; Kato Y
    Int J Hematol; 1995 Apr; 61(3):123-9. PubMed ID: 7541257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy.
    Zagonel V; Babare R; Merola MC; Talamini R; Lazzarini R; Tirelli U; Carbone A; Monfardini S
    Ann Oncol; 1994; 5 Suppl 2():127-32. PubMed ID: 7515645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kinetics of circulating hematopoietic stem cells following chemotherapy in patients with hematopoietic malignancies].
    Tamura K; Kosaka M; Mizuguchi T; Miyamoto Y
    Rinsho Ketsueki; 1990 May; 31(5):647-54. PubMed ID: 1697629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.
    Ema H; Suda T; Sakamoto S; Tomonaga T; Tsunoda J; Muroi K; Komatsu N; Miwa A; Ohsaka A; Yoshida M
    Jpn J Cancer Res; 1989 Jun; 80(6):577-82. PubMed ID: 2474526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of rG-CSF on the morphology and function of neutrophils in ovarian cancer chemotherapy].
    Hoshino T; Suzuki Y; Adachi T; Okabe K; Takayama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1320-4. PubMed ID: 7505028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of recombinant human granulocyte colony-stimulating factor in patients receiving chemotherapy for urogenital cancer. Urological rhG-CSF Study Group.
    Aso Y; Akaza H
    J Urol; 1992 Apr; 147(4):1060-4. PubMed ID: 1372661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer.
    Seidman AD; Scher HI; Gabrilove JL; Bajorin DF; Motzer RJ; O'Dell M; Curley T; Dershaw DD; Quinlivan S; Tao Y
    J Clin Oncol; 1993 Mar; 11(3):408-14. PubMed ID: 7680373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of acute myeloblastic leukemia invaded uterine cervix-diagnosed by changes in peripheral blood after G-CSF administration].
    Ohta T; Takeuchi S; Ohara N; Deguchi M; Mochizuki M; Kitazawa S; Maeda S
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1337-40. PubMed ID: 7505029
    [No Abstract]   [Full Text] [Related]  

  • 38. Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma.
    Pettengell R; Testa NG; Swindell R; Crowther D; Dexter TM
    Blood; 1993 Oct; 82(7):2239-48. PubMed ID: 7691253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial.
    Kaku K; Takahashi M; Moriyama Y; Nakahata T; Masaoka T; Yoshida Y; Shibata A; Kaneko T; Miwa S
    Leuk Lymphoma; 1993 Oct; 11(3-4):229-38. PubMed ID: 8260897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors.
    Danova M; Barni S; Del Mastro L; Danesi R; Pappagallo GL
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1303-13. PubMed ID: 21916584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.